Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Print1
- Exam Prep1
- Article Type
- Clinical Trial1
- Clinical Study1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Clin Endocrinol (Oxf)1
Search Results
Sort by
- BookAmerican College of Physicians.Contents:
Part A: [v. 1] Cardiovascular medicine
[v. 2] Dermatology
[v. 3] Gastroenterology and hepatology
[v. 4] Hematology and oncology
[v. 5] Neurology
[v. 6] Rheumatology
Part B: [v. 7] Endocrinology and metabolism
[v. 8] General internal medicine
[v. 9] Infectious disease
[v. 10] Nephrology
[v. 11] Pulmonary and critical care medicine
[v. 12] Cumulative index. - ArticleDavies TF, Gomez-Pan A, Watson MJ, Mountjoy CQ, Hanker JP, Besser GM, Hall R.Clin Endocrinol (Oxf). 1977 Mar;6(3):213-8.Ten endocrinologically normal men with secondary sexual impotence were given 500 microng LHRH subcutaneously every 8 h. After 4 weeks treatment the LH response to 500 microng LHRH was reduced from a peak of 35.7+/-5.2 to 16.8+/-3.5 mu/ml (P less than 0.01) and the FSH response from 4.2+/-0.93 to 2.39+/-0.4 mu/ml (P greater than 0.01). Circulating total testosterone, oestradiol, prolactin and sex hormone binding globulin showed no significant changes. Whether this inability of the pituitary to maintain it s response to LHRH is peculiar to impotent men requires further study.